1 Hopital Edouard Herriot, Poitiers, France Serum PSA level is associated with peri operative and pathological prognostic indicators. Although there is a statistically signi®cant relationship between serum PSA level and tumour extent, in cases of the same tumour volume or grade, serum PSA levels range from less than 4 ng/ml to more than 10 ng/ml. Previous immuno histochemical studies from human prostate cancer samples have failed to explain the variability of PSA production. The objective of our study was to assess the relationship between the level of tissue PSA RNA from normal and prostate cancer biopsies and the level of PSA.
Method
Prostate biopsies were obtained from 153 patients with an abnormal DRE or a PSA more than 4 ng/ml or symptoms of BPH and a PSA more than 4 ng/ml. Total RNA was extracted from fresh frozen specimens of tissue samples. Detection of PSA transcript compared to GADPH transcripts was done using RT-PCR. The level of tissue PSA RNA was semi quantitatively assessed from electrophoresis gels and compare to clinical and pathological parameters (chi square test) and to serum PSA levels (analysis of variance).
Results
Biopsy results showed that 108 patients had prostate cancer (average Gleason score 6.39 AE 0.74) and 45 patients had BPH. In all cases of non-tumoural prostate biopsies, the level of tissue PSA RNA was at the lowest level compared to prostate cancer samples and not related to PSA levels. In prostate cancer samples, tissue PSA RNA was associated with the level of serum PSA (P`0.01) as demonstrated in Figure 1 . On the other hand, tissue PSA RNA level was not associated with other prognostic indicators such as grade, tumour volume, capsular penetration, seminal vesicle invasion or positive margins.
Conclusion
These results suggest that serum PSA level is a very sensitive test for prostate cancer because tumour cells have an increased transcription of the gene. Transcriptional factors of the PSA gene should be studied further to explain the prognostic implication of this marker. 
